» Articles » PMID: 15870263

Regulation of the Deubiquitinating Enzyme CYLD by IkappaB Kinase Gamma-dependent Phosphorylation

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2005 May 5
PMID 15870263
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor suppressor CYLD is a deubiquitinating enzyme (DUB) that inhibits the ubiquitination of key signaling molecules, including tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2). However, how the function of CYLD is regulated remains unknown. Here we provide evidence that inducible phosphorylation of CYLD is an important mechanism of its regulation. Under normal conditions, CYLD dominantly suppresses the ubiquitination of TRAF2. In response to cellular stimuli, CYLD undergoes rapid and transient phosphorylation, which is required for signal-induced TRAF2 ubiquitination and activation of downstream signaling events. Interestingly, the CYLD phosphorylation requires IkappaB kinase gamma (IKKgamma) and can be induced by IKK catalytic subunits. These findings suggest that CYLD serves as a novel target of IKK and that the site-specific phosphorylation of CYLD regulates its signaling function.

Citing Articles

The CYLD-PARP1 feedback loop regulates DNA damage repair and chemosensitivity in breast cancer cells.

Zheng M, Wang S, Tang K, Kong R, Wang X, Zhou J Proc Natl Acad Sci U S A. 2024; 122(1):e2413890121.

PMID: 39739815 PMC: 11725943. DOI: 10.1073/pnas.2413890121.


TBK1 and Caspase-8 suppress necroptosis but activate NLRP3 inflammasome activation during CXCL4 and TLR8 costimulation.

Cui Y, Zhang Y, Yang C Cell Death Discov. 2024; 10(1):511.

PMID: 39715768 PMC: 11666742. DOI: 10.1038/s41420-024-02280-0.


Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer.

Mussa A, Ismail N, Hamid M, Al-Hatamleh M, Bragoli A, Hajissa K J Exp Clin Cancer Res. 2024; 43(1):312.

PMID: 39609700 PMC: 11603874. DOI: 10.1186/s13046-024-03218-1.


Cyld restrains the hyperactivation of synovial fibroblasts in inflammatory arthritis by regulating the TAK1/IKK2 signaling axis.

Rinotas V, Iliaki K, Pavlidi L, Meletakos T, Mosialos G, Armaka M Cell Death Dis. 2024; 15(8):584.

PMID: 39122678 PMC: 11316070. DOI: 10.1038/s41419-024-06966-2.


The acetylase activity of Cdu1 regulates bacterial exit from infected cells by protecting effectors from degradation.

Bastidas R, Kedzior M, Davidson R, Walsh S, Dolat L, Sixt B Elife. 2024; 12.

PMID: 38358795 PMC: 10942603. DOI: 10.7554/eLife.87386.


References
1.
Wang C, Deng L, Hong M, Akkaraju G, Inoue J, Chen Z . TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 2001; 412(6844):346-51. DOI: 10.1038/35085597. View

2.
Bignell G, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R . Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet. 2000; 25(2):160-5. DOI: 10.1038/76006. View

3.
Silverman N, Maniatis T . NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev. 2001; 15(18):2321-42. DOI: 10.1101/gad.909001. View

4.
Waterfield M, Xiao G, Fong A, Sun S . NF-kappaB signaling pathway governs TRAIL gene expression and human T-cell leukemia virus-I Tax-induced T-cell death. J Biol Chem. 2001; 276(44):40385-8. DOI: 10.1074/jbc.C100501200. View

5.
Xiao G, Cvijic M, Fong A, Harhaj E, Uhlik M, Waterfield M . Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha. EMBO J. 2001; 20(23):6805-15. PMC: 125766. DOI: 10.1093/emboj/20.23.6805. View